Difference between revisions of "Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5 (Q9577)"
Jump to navigation
Jump to search
(Created claim: title (P93): A gain-of-function mutation of JAK2 in myeloproliferative disorders, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 1779-1790, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 1779-1790 | ||
| Property / Page(s): 1779-1790 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:37, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kralovics R
0 references
2005
0 references
N. Engl. J. Med.
0 references
352
0 references
A gain-of-function mutation of JAK2 in myeloproliferative disorders (English)
0 references
1779-1790
0 references
